CORALVILLE, Iowa, Dec. 16 /PRNewswire-FirstCall/ -- Vivakor, Inc. (OTC Bulletin Board: VIVK) has signed a Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida. Baker Consulting has been retained by Vivakor to assist with business development, financing and assisting the company with its recently reported acquisition strategy. Specifically, Baker Consulting is exploring potential acquisition targets for Vivakor in the areas of ophthalmological devices and treatment solution companies as well as other targets aligned with Vivakor's existing divisions. In addition to vetting and presenting specific opportunities, Baker Consulting is continuing to present financing opportunities for these transactions as well as for Vivakor's existing operations. About Vivakor, Inc. Vivakor is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/. FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products, markets and business strategies. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes. Contact: Vivakor Investor Relations c/o IME Advisors (888) 648-8485 DATASOURCE: Vivakor, Inc. CONTACT: Vivakor Investor Relations, c/o IME Advisors, 1-888-648-8485 Web Site: http://www.vivakor.com/

Copyright